darzalex – Lab DB

Pharmaceutical R&D

Darzalex Secures Landmark European Approval for Self-Administration in Multiple Myeloma, Ushering in a New Era of Home-Based Cancer Care

Teuku Ryan Mar 28, 2026 0

Johnson & Johnson’s (J&J) groundbreaking cancer immunotherapy, Darzalex (daratumumab), has achieved a pivotal milestone in its European market penetration with…

Darzalex Secures Landmark European Approval for Self-Administration in Multiple Myeloma, Ushering in a New Era of Home-Based Cancer Care

YOU MAY HAVE MISSED

First Blueprint of Human Skeletal Development Reveals Origins of Bone Health and Disease Across the Lifespan

From list price to net price: How finance leaders decode real drug costs

Immune System Response in the Brain Identified as Primary Cause for Early Olfactory Loss in Alzheimer’s Disease

Atomic Roaming and the Hidden Drivers of Radiation Damage: A Breakthrough in Molecular Physics